Skip to main content
HHS
NASDAQ Trade & Services

Harte Hanks Reports Revenue Decline, Reduced Net Loss, and Extends Key Credit Facility to 2028

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$2.67
Mkt Cap
$19.797M
52W Low
$2.33
52W High
$5.39
Market data snapshot near publication time

summarizeSummary

Harte Hanks Inc. reported a significant revenue decline for 2025, but substantially reduced its net loss compared to the prior year, largely due to the absence of one-time pension termination charges. The company also secured an extension of its $25 million credit facility until 2028, enhancing its liquidity and financial flexibility.


check_boxKey Events

  • Revenue Decline Across Segments

    Total operating revenue decreased by 13.9% to $159.6 million in 2025, down from $185.2 million in 2024, with declines across all three business segments: Revenue Solutions (-30.2%), Fulfillment & Logistics Services (-9.3%), and Customer Care (-5.4%).

  • Significant Reduction in Net Loss

    The company reported a net loss of $0.8 million in 2025, a substantial improvement from a $30.3 million net loss in 2024. This improvement was primarily due to the absence of a $37.5 million pension termination charge recorded in 2024.

  • Credit Facility Extended with Expansion Option

    The $25.0 million asset-based revolving credit facility with Texas Capital Bank was extended for three years to June 30, 2028. The facility also includes an accordion feature allowing the company to seek up to an additional $10.0 million in commitments.

  • Ongoing Restructuring Efforts

    Harte Hanks incurred $1.8 million in restructuring charges in 2025 as part of 'Project Elevate,' a program aimed at optimizing business resources and reinvesting savings. Total estimated cost reductions from this program for 2024-2025 are $16.0 million.


auto_awesomeAnalysis

Harte Hanks' 2025 annual report presents a mixed financial picture. While the company experienced a notable 13.9% decline in operating revenue and an 81.6% drop in operating income, the significant reduction in net loss from $30.3 million to $0.8 million is a positive development, albeit largely attributable to the absence of a substantial pension termination charge incurred in 2024. Crucially, the extension of the $25.0 million credit facility until June 2028, along with an accordion feature for an additional $10.0 million, provides essential liquidity and financial stability for this micro-cap company. This financing arrangement, which is larger than the company's current market capitalization, is a strong signal of lender confidence and significantly extends the company's operational runway. Management's statement that there is no substantial doubt about its ability to continue as a going concern further reinforces this stability. Investors should monitor the company's ability to stabilize and grow revenue in the coming quarters, as operational performance remains a key challenge despite improved financial flexibility.

At the time of this filing, HHS was trading at $2.67 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $19.8M. The 52-week trading range was $2.33 to $5.39. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HHS - Latest Insights

HHS
Mar 17, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
7